Skip to content

Clinical trials

Terminated Skin Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Skin Neoplasms Status: Terminated Country / region: United States Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20072
20084
20094
20102
20119
20124
20132
20143
20152
20174
20183
20191
20203
20211
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated49

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)10
M.D. Anderson Cancer Center3
New Mexico Cancer Research Alliance3
Case Comprehensive Cancer Center2
Clinigen, Inc.2
Anne Chang1
Bristol-Myers Squibb1
Calando Pharmaceuticals1
Celldex Therapeutics1
CureOne1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Skin Neoplasms49
Melanoma35
Neoplasms8
Lung Neoplasms6
Neoplasm Metastasis6
Breast Neoplasms5
Head and Neck Neoplasms5
Basal Cell Carcinoma4
Carcinoma, Merkel Cell3
Cutaneous Squamous Cell Carcinoma3

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.